Navegando por Palavras-chave "Mycophenolate Sodium"
Agora exibindo 1 - 1 de 1
Resultados por página
Opções de Ordenação
- ItemSomente MetadadadosComparação Entre Everolimo E Micofenolato De Sódio Em Receptores De Transplante Renal Com Doadores Falecidos De Critérios Expandidos(Universidade Federal de São Paulo (UNIFESP), 2018-12-04) Ferreira, Alexandra Nicolau [UNIFESP]; Silva Junior, Helio Tedesco [UNIFESP]Introduction. The Use Of Expanded Criteria Donors (Ecd) For Kidney Transplantation Has Been A New Strategy To Increase The Number Of Deceased Donor Kidneys Available In The World. However, The Incidence Of Delayed Graft Function (Dgf), Acute Rejection And Nephrotoxic Events Is More Often In Ecd Kidneys Recipients Than Standard Criteria Donor Kidneys Recipients. The Optimal Immunosuppressive Regimen For Recipients Of Ecd Kidneys Has Not Been Defined. Methods. In This Single-Center Study, 171 Recipients Of Ecd Kidney Transplants Were Randomized To Receive Antithymocyte Globulin Induction, Delayed Introduction Of Reduced Dose Tacrolimus, Prednisone And Everolimus (R-Atg/Evr, N=88) Or Mycophenolate (R-Atg/Mps, N=83). No Cytomegalovirus (Cmv) Pharmacological Prophylaxis Was Used. The Primary End-Point Was The Incidence Of Cmv Infection/Disease In The Intention-To-Treat Population At 12 Months. Secondary Endpoints Included Treatment Failure (First Biopsy Proven Acute Rejection [Bpar], Graft Loss Or Death) And Safet